If a gene change that has not been previously reported is considered pathogenic, confirming its pathogenicity often requires demonstrating the same variant in another affected first-degree relative (11).The clinical diagnosis of MEN1 relies on detecting neoplastic disorders in at least two organs typically involved, such as the parathyroid glands, the anterior pituitary, and the pancreas. Here, MEN1 is linked to neoplastic disease or syndrome.